Innoviva, Inc. (INVA)

21.04 +0.01 (+0.05%) USD  |  NASDAQ  |  Aug 25, 12:12
More

Innoviva Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for INVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 20, 2026 --
August 10, 2026 --
August 07, 2026 --
August 06, 2026 --
June 22, 2026 --
June 01, 2026 --
May 26, 2026 --
May 14, 2026 --
May 07, 2026 --
April 07, 2026 --
March 31, 2026 --
March 02, 2026 --
February 26, 2026 --
February 17, 2026 --
December 31, 2025 --
December 16, 2025 --
December 14, 2025 --
December 12, 2025 --
Date Value
November 17, 2025 --
November 10, 2025 --
November 07, 2025 --
November 06, 2025 --
September 30, 2025 --
August 11, 2025 --
August 06, 2025 --
July 14, 2025 --
July 11, 2025 --
June 30, 2025 --
May 07, 2025 --
March 03, 2025 --
December 31, 2024 --
November 07, 2024 --
September 30, 2024 --
August 09, 2024 --
August 06, 2024 --
August 01, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Zevra Therapeutics, Inc. Upgrade
Collegium Pharmaceutical, Inc. Upgrade
CorMedix, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade